Search

everythinglearnresearchcommunity

for

Search:↓

Mohs micrographic surgery is effective for treating basal cell carcinoma on the eyelid, while radiotherapy has higher recurrence rates, and topical vitamin D3 may reduce and delay BCC formation in mice.

Applying the anti-cancer drug Bortezomib to skin can promote hair growth and increase hair proteins through the GATA-3 factor.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Chemotherapy often causes hair loss, which is distressing for many, but usually reversible.

Some pediatric Ewing's sarcoma patients may experience permanent hair loss after chemotherapy, and treatments might not fully restore hair.

Chemotherapy can cause significant but usually reversible hair loss, and managing it involves patient education and hair care strategies.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Families help manage chemotherapy side effects at home by providing preferred foods, keeping hair short, assisting with routines, and ensuring hydration.

Radiation therapy is an effective treatment for severe scalp cellulitis with mild side effects and no long-term complications.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

The drug combination was safe and showed promise in treating advanced tumors.

Improving treatment plans can reduce hair loss and improve life quality for ovarian cancer patients.

Scalp cooling is an effective and safe way to prevent hair loss from chemotherapy, with manageable side effects and low risk of scalp cancer.

Ascorbigen increases hair cell growth in a lab setting but does not prevent hair loss from chemotherapy in mice.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Anthracycline and taxane chemotherapy cause significant side effects like fatigue, vomiting, nausea, nerve damage, joint pain, and hair loss in breast cancer patients.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Blocking specific proteins can help remove aging cells and might treat age-related diseases and promote hair growth.

Chemotherapy affects blood vessels in hair follicles, not stem cells, allowing hair regrowth.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

Thymosin beta 4 protects cells from damage by blocking a harmful microRNA and boosting a protective gene.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Fenugreek seeds and Butea monosperma flowers may help reduce hair loss from chemotherapy.